SCHEMBL20202052

SCHEMBL20202052

Cc1ccc(N2c3ccccc3C3(c4ccccc42)c2cccc4c2N2c5c3cccc5C3(c5ccccc5N(c5ccc(C)cc5)c5ccccc53)c3cccc(c32)C42c3ccccc3N(c3ccc(C)cc3)c3ccccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.41
ELANE P08246 2/20 0.37
F2 P00734 1/20 0.37
CTSG P08311 1/20 0.37
CMA1 P23946 1/20 0.37
CTRC Q99895 1/20 0.37
MGLL Q99685 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADORA2A P29274 1/20 0.33
SLC6A2 P23975 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
TLR9 Q9NR96 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20202038 0.86 ALDH1A1 (0.39) PGRELANEMGLLALDH1A1MEN1
SCHEMBL20202036 0.83 ALDH1A1 (0.35) PGRMGLLALDH1A1SMN1; SMN2MEN1
SCHEMBL20202037 0.82 ALDH1A1 (0.39) PGRELANEMGLLALDH1A1MEN1
SCHEMBL16389537 0.82 ALDH1A1 (0.43) PGRELANEF2CTSGCMA1
SCHEMBL20383155 0.82 PGR (0.40) PGRELANEALDH1A1MEN1GAA
SCHEMBL19654706 0.81 SMN1; SMN2 (0.44) PGRELANEF2CTSGCMA1
SCHEMBL20202043 0.80 ALDH1A1 (0.35) PGRALDH1A1SMN1; SMN2MEN1GAA
SCHEMBL20202041 0.80 ALDH1A1 (0.35) PGRALDH1A1SMN1; SMN2MEN1GAA
SCHEMBL16389447 0.80 RAB9A (0.46) PGRALDH1A1SMN1; SMN2ADORA2ASLC6A2
SCHEMBL11978689 0.79 PGR (0.53) PGRELANEF2CTSGCMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10787467-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-09-29 US disclosed
US-20180148462-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-31 US disclosed
US-20180148462-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148462-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME PKD1, ODC1, PIEZO1 PGR 844/4885ELANE 3156/4885F2 657/4885
US-10787467-B2 Polycyclic compound and organic electroluminescence device including the same PKD1, ODC1, PIEZO1 PGR 844/4885ELANE 3156/4885F2 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.